Gregory Bailey, Director at Serina Therapeutics, Inc. (SER), bought 1,422 shares at $9.50 ($14K) on 2024-05-21, disclosed to the SEC on 2024-05-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| BHVN | BUY | 2024-09-25 | $221K | — | Filing → |
| SER | BUY | 2024-09-24 | $7K | — | Filing → |
| SER | BUY | 2024-09-20 | $88K | — | Filing → |